Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/03/2002WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002WO2002077210A2 Methods to culture circovirus
10/03/2002WO2002077209A1 Transgenic plants with resistance against tobacco rattle virus and corresponding nucleotide sequence
10/03/2002WO2002077206A1 Compositiona and methods useful for hcv infection
10/03/2002WO2002077202A1 Culture medium for cell growth and transfection
10/03/2002WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002WO2002077189A2 Glycosylation-resistant and nonglycosylated cyanovirins
10/03/2002WO2002077185A2 Methods for modifying flowering phenotypes
10/03/2002WO2002077184A2 Oligonucleotide conjugates
10/03/2002WO2002077182A2 Compounds displayed on icosahedral phage and methods of using same
10/03/2002WO2002077179A2 Leinamycin biosynthesis gene cluster and its components and their uses
10/03/2002WO2002077178A2 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use
10/03/2002WO2002077177A2 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity
10/03/2002WO2002077175A2 Method for generating cloned animals using chromosome shuffling
10/03/2002WO2002077174A2 Human cytokine receptor
10/03/2002WO2002077170A2 Expansin protein and polynucleotides and methods of use
10/03/2002WO2002077168A2 Mch1r deficient mice
10/03/2002WO2002077165A2 Glycoconjugate synthesis using a pathway-engineered organism
10/03/2002WO2002077164A2 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
10/03/2002WO2002077163A2 Drought- and salt-resistant plants by abi5 overexpression
10/03/2002WO2002077161A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses
10/03/2002WO2002077159A2 End group activated polymers with oligonucleotide ligands
10/03/2002WO2002077158A2 Root specific, stimulant inducible promoter and its use
10/03/2002WO2002077152A1 Device and method for detection of multiple analytes
10/03/2002WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002WO2002077030A2 Modified mhc molecules whose binding to cd8 or cd4 is inhibited and use thereof
10/03/2002WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002WO2002077026A2 Gene involved in v(d)j recombination and/or dna repair
10/03/2002WO2002077024A1 Shellfish protein
10/03/2002WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002WO2002077021A2 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002WO2002077020A2 Virulence genes in h. influenzae
10/03/2002WO2002077005A1 Pesticidal spinosyn derivatives
10/03/2002WO2002076510A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002WO2002076508A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002WO2002076507A2 Uses of opg ligand to modulate immune responses
10/03/2002WO2002076486A2 Histidine-rich glycoprotein
10/03/2002WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002WO2002076406A2 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
10/03/2002WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002WO2002076389A2 Compositions and methods to prevent metastasis from primary malignancies
10/03/2002WO2002076380A2 Cytotoxic factors for modulating cell death
10/03/2002WO2002076280A2 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer
10/03/2002WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002WO2002076205A2 Compositions and methods of zearalenone detoxification
10/03/2002WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002WO2002076195A1 Ras p27 animal models and uses thereof
10/03/2002WO2002076189A1 Method of enhancing entomophilous
10/03/2002WO2002068687A8 Function and application of tob gene in central nervous system of mammal
10/03/2002WO2002063039A3 Gene silencing gene
10/03/2002WO2002062944A3 Novel physiologically active peptide and use thereof
10/03/2002WO2002062818A3 Antisense modulation of casein kinase 2-alpha expression
10/03/2002WO2002062297A3 Methods and compositions for modulating gluconeogenesis using pgc-1
10/03/2002WO2002059153A3 Anticoagulants and their uses
10/03/2002WO2002058728A3 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/03/2002WO2002057424A3 Nucleic acid delivery formulations
10/03/2002WO2002056828A3 Helper virus-free herpes virus amplicon particles and uses thereof
10/03/2002WO2002055727A3 Methods and reagents for the isolation of nucleic acids
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002WO2002044376A9 Modulation of gene expression using insulator binding proteins
10/03/2002WO2002044206A3 Membrane fusion proteins derived from reovirus
10/03/2002WO2002043658A9 Fcrn-based therapeutics for the treatment of auto-immune disorders
10/03/2002WO2002040694A3 Heterologous expression of taxanes
10/03/2002WO2002033057A3 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
10/03/2002WO2002031173A3 Improved method for the biosynthesis of vitamin e
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002029073A3 Gene delivery vectors for stem cells
10/03/2002WO2002029068A3 Virus-based amplification vector for plants
10/03/2002WO2002026944A3 METHODS AND COMPOSITIONS EMPLOYING A NOVEL STEAROYL-CoA DESATURASE-hSCD5
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002WO2002024896A9 Screening assays for agonists or antagonists of receptor activat or of nf-kb
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002018611A3 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
10/03/2002WO2002018595A3 Moraxella polypeptides and corresponding dna fragments and uses thereof
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002016422A3 Recombinant constructs of borrelia burgdorferi
10/03/2002WO2002014494A3 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
10/03/2002WO2002008440A3 Fermentation process for epothilones
10/03/2002WO2002002751A3 Alteration of cell membrane
10/03/2002WO2002000902A3 Regulation of anthocyanin pigment production
10/03/2002WO2002000242A3 Human papilloma virus treatment
10/03/2002WO2001098515A3 Gene-regulating conjugates
10/03/2002WO2001098355A3 Cgi-69 compositions and methods of use
10/03/2002WO2001096608A8 Detection of nucleic acids by type-specific hybrid capture method
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001094627A3 Assay techniques based on growth stage dependent expression in c. elegans
10/03/2002WO2001093836A3 Encapsulation of polynucleotides and drugs into targeted liposomes
10/03/2002WO2001092309A3 Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
10/03/2002WO2001083754A3 Cellular regulators of infectious agents and methods of use
10/03/2002WO2001079501A3 Nucleic acid coding for at least one raf partial sequence with a mekk1 binding site
10/03/2002WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity
10/03/2002WO2001074862A3 Method for the production of bacterial toxins
10/03/2002WO2001073077A3 Regulation of human serine racemase enzyme
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001070976A3 Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer
10/03/2002WO2001029230A9 Engineering disease resistance with pectate lyase-like genes
1 ... 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 ... 4023